Alternate-day fasting elicits larger changes in fat mass than time-restricted eating in adults without obesity – A randomized clinical trial
Clinical Nutrition · 2025-10 · 53 · 212-221
DOI: 10.1016/j.clnu.2025.08.033 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nutrition, 2025-10. Verfasst von Nina Derron und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), 8091 Zurich and University of Zurich (UZH), 8006 Z…. Hauptthemen laut MEDLINE: Fasting, Overweight, Adipose Tissue. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND & AIMS: Intermittent fasting (IF) is a popular nutritional strategy for weight control and improved metabolic health, however it is unclear which type of intermittent fasting is most effective. This randomized trial directly compared short-term alternate-day fasting (ADF) and time-restricted eating (TRE) with controls in adults with overweight or a high normal weight. The aim was to compare the effects of ADF and TRE versus controls regarding whole-body fat mass loss, weight control and cardiometabolic health. METHODS: In this 4-week, parallel-arm, randomized clinical trial (February 2021-May 2022), participants aged 18-40 years with a body mass index between 23 and 30 kg/m2 were assigned to ADF (alternating fasting and ad libitum eating days), to TRE (eating only between 12:00-20:00), or control (no change in eating times). The primary outcome was change in total fat volume (assessed by whole-body magnetic resonance imaging). Secondary outcomes were subcutaneous and visceral fat mass, body weight, resting metabolic rate, biochemical markers, energy intake, activity energy expenditure and health-related quality of life. RESULTS: Seventy-six participants (mean [standard deviation (SD)] age, 29.6 [5.6] years; body mass index, 25.8 [2.2] kg/m2; 34 [44 %] female) were randomized to ADF (n = 26), TRE (n = 26), or control (n = 24). Seventy-five participants completed the trial (25 in ADF, 26 in TRE, 24 in control). ADF led to a greater reduction in total fat volume than control (mean difference -1059.8 cm3, 95 % CI: -1380.0 cm3 to -739.6 cm3, p < 0.001) and TRE (-695.7 cm3, 95 % CI: -1013.9 to -377.6 cm3, p < 0.001). TRE also reduced total fat volume compared to control (-364.0 cm3, 95 % CI: -621.3 cm3 to -106.7 cm3, p = 0.007). Energy intake was reduced by 34 % [18 %] in ADF, 15 % [21 %] in TRE and 3 % [22 %] in control. ADF, but not TRE, reduced visceral fat mass, resting metabolic rate, triiodothyronine and non-HDL cholesterol compared to controls. Only ADF increased activity energy expenditure and health-related quality of life. No serious adverse events occurred. CONCLUSIONS: In this randomized clinical trial, ADF was more effective in reducing energy intake than TRE which has subsequent effects on fat mass and body weight. Only ADF improved several cardiometabolic risk factors. REGISTRATION: https://clinicaltrials.gov/study/NCT04732130; Unique identifier: NCT04732130.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), 8091 Zurich and University of Zurich (UZH), 8006 Zurich, Switzerland. Electronic address: nina.derron@usz.ch.
- Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), 8091 Zurich and University of Zurich (UZH), 8006 Zurich, Switzerland; Human-centered Sensing Laboratory, Department of M…
- Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), 8091 Zurich and University of Zurich (UZH), 8006 Zurich, Switzerland.
- Departments of Biostatistics and Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, 8001 Zurich, Switzerland.
- Department of Radiology, University Hospital Zurich, 8091 Zurich, Switzerland.
- Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland; PHRT Swiss Multi-Omics Center, 8093 Zurich, Switzerland.
Zitieren
APA
Derron, N., Güntner, A. T., Weber, I. C., Braun, J., Koska, İ. Ö., Othman, A., Mönch, L., von Eckardstein, A., Puhan, M. A., Beuschlein, F., Hochuli, M., Zamboni, N., Guggenberger, R., & Gerber, P. A. (2025). Alternate-day fasting elicits larger changes in fat mass than time-restricted eating in adults without obesity – A randomized clinical trial. Clinical Nutrition, 53, 212-221. https://doi.org/10.1016/j.clnu.2025.08.033
Vancouver
Derron N, Güntner AT, Weber IC, Braun J, Koska İÖ, Othman A, et al. Alternate-day fasting elicits larger changes in fat mass than time-restricted eating in adults without obesity – A randomized clinical trial. Clinical Nutrition. 2025;53:212-221. doi:10.1016/j.clnu.2025.08.033
BibTeX
@article{Derron2025,
author = {Derron, Nina and Güntner, Andreas T and Weber, Ines C and Braun, Julia and Koska, İlker Ö and Othman, Alaa and Mönch, Leonie and von Eckardstein, Arnold and Puhan, Milo A and Beuschlein, Felix and Hochuli, Michel and Zamboni, Nicola and Guggenberger, Roman and Gerber, Philipp A},
title = {Alternate-day fasting elicits larger changes in fat mass than time-restricted eating in adults without obesity – A randomized clinical trial},
journal = {Clinical Nutrition},
year = {2025},
volume = {53},
pages = {212--221},
doi = {10.1016/j.clnu.2025.08.033}
}
EUVIMED